Previous Close | 214.82 |
Open | 215.56 |
Bid | 215.98 x 100 |
Ask | 216.24 x 100 |
Day's Range | 214.76 - 218.66 |
52 Week Range | 189.44 - 319.76 |
Volume | |
Avg. Volume | 1,307,263 |
Market Cap | 31.468B |
Beta (5Y Monthly) | -0.01 |
PE Ratio (TTM) | 27.05 |
EPS (TTM) | 7.99 |
Earnings Date | Jul 23, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 284.76 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue by 27% in Q1, Provides Weak Outlook for FY ’24 The market […]